InfinixBio’s Post

View organization page for InfinixBio, graphic

1,662 followers

Tom Zupancic, our Chief Scientific Office, recently shared his insights at the Ohio House of Representatives, advocating for the transformative potential of House Bill 434. This bill aims to position Ohio as a leader in developing effective therapies for traumatic brain injuries and other neurodegenerative conditions. As a board member of the Brain Injury Research Foundation (BIRF), Tom was one of six expert presenters. He highlighted the urgent need for innovative treatments and the role that comprehensive programs like PRECEPT and SynapFx could play in revolutionizing TBI research and therapy. By fostering statewide collaboration and leveraging multiomics data for combination therapies, we can enhance our approach to these pressing health challenges.  #Neuroscience #TraumaticBrainInjury #GeneTherapy

To view or add a comment, sign in

Explore topics